Skip to main content
OpenTrials
Completed

NCT Number: NCT00756704

The Effectiveness of Smoking Cessation Guidelines in the Emergency Department

Although 78% of smokers report that a health professional has previously advised them to quit smoking, most smokers are not advised to stop smoking or offered assistance with smoking cessation during a given ED visit. There are multiple barriers to routine implementation of smoking cessation guidelines by emergency clinicians, however, and rigorously performed clinical trials are needed to demonstrate that routine screening and counseling of ED patients results in increased quit rates. To determine the feasibility of implementing the Agency for Healthcare Research and Quality (AHRQ) Smoking Cessation Guideline in the ED, we will conduct a clinical trial in 974 ambulatory adult smokers who present to 2 emergency departments, using a pre-post design. During the 3-month baseline period, clinicians will perform their usual duties but will not receive training in use of the AHRQ Guideline. Based on the Chronic Care Model, the 3-month intervention period will include: 1) a tutorial on brief cessation counseling for ED nurses and physicians, 2) use of an ED algorithm that includes recommended tobacco counseling items, 3) fax referral of motivated smokers to Quitline Iowa for proactive telephone counseling plus free nicotine replacement therapy, and 4) group and individual feedback to ED staff. We will conduct exit interviews of ED patients to assess performance of guideline-recommended actions by ED staff and 3- and 6-month telephone follow-up to determine 7-day point-prevalence abstinence (with biochemical confirmation of self-reported quitters at 6 months). Our main analyses will examine the contrast between the intervention and control periods in the performance of guideline-recommended actions and in 6-month quit rates, using hierarchical logistic regression to adjust for baseline differences in potentially confounding patient variables. In secondary analyses, we will assess the change in attitudes of ED nurses and physicians toward smoking cessation counseling. This feasibility study will determine the receptivity of patients and ED staff to the guideline-based intervention and will provide estimates of effect size in planning a full scale multi-site clinical trial of the study intervention in community hospital EDs.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Iowa Methodist Medical Center, Des Moines, Iowa, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presentation to the Emergency Department by private vehicle or on a walk-in basis
  • Current cigarette smoker (5 or more cigarettes per day)

Exclusion criteria

  • Acute medical decompensation (e.g., acute respiratory failure requiring intubation, cardiac arrest, cardiogenic or septic shock)
  • Life-threatening trauma
  • Altered mental status
  • Dementia
  • Language barrier
  • Incarceration
  • Transfer to another ED
  • Departure from the ED prior to evaluation
  • Inability to be contacted by telephone
  • ED presentation for sexual assault
  • ED presentation for acute psychiatric crisis (e.g., suicidal ideation)
  • Participation in a smoking cessation program in the past 3 months

Treatment and study plan

Smoking Cessation Guideline Implementation

Behavioral
  • a tutorial on brief cessation counseling for ED nurses and physicians
  • use of an ED algorithm that includes recommended tobacco counseling items
  • fax referral of motivated smokers to Quitline Iowa for proactive telephone counseling plus free nicotine replacement therapy
  • group feedback to ED staff

Primary outcomes

  1. Performance of smoking cessation guideline-recommended actions by ED staff

    Time frame: Assessed within two weeks after discharge from ED

Secondary outcomes

  1. 7-day point-prevalence smoking abstinence

    Time frame: 3 and 6 months post enrollment

Sponsors and collaborators

Lead sponsor

University of Iowa

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2008
Primary completion
2011
Study completion
2011
First posted
Sep 22, 2008
Registry last updated
Nov 4, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.